Betaine ( DrugBank: Betaine )


2 diseases
IDDisease name (Link within this page)Number of trials
201Angelman syndrome1
337Homocystinuria1

201. Angelman syndrome


Clinical trials : 24 Drugs : 35 - (DrugBank : 9) / Drug target genes : 22 - Drug target pathways : 20
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00348933
(ClinicalTrials.gov)
July 20063/7/2006Dietary Supplements for the Treatment of Angelman SyndromeEfficacy of a Therapeutic Treatment Trial in Angelman SyndromeAngelman Syndrome;Nervous System DiseasesDrug: Betaine;Drug: Creatine;Drug: Metafolin;Drug: Vitamin B12University of California, San DiegoBaylor College of Medicine;Rady Children's Hospital, San Diego;Boston Children’s Hospital;Greenwood Genetic Center;Rare Diseases Clinical Research NetworkCompletedN/A5 YearsAll90N/AUnited States

337. Homocystinuria


Clinical trials : 13 Drugs : 13 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 23
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02404337
(ClinicalTrials.gov)
July 20156/3/2015Betaine METABOLISM OF PATIENTS With HomocystinuriaBetaine METABOLISM OF PATIENTS With HomocystinuriaHomocystinuriaDrug: BetaineAssistance Publique - Hôpitaux de ParisNULLCompleted1 Year18 YearsAll12Phase 2France